The plasma lipidome varies with the severity of metabolic dysfunction-associated steatotic liver disease
2024

Plasma Lipids as Biomarkers for Liver Disease

Sample size: 39 publication 10 minutes Evidence: moderate

Author Information

Author(s): Heymann Clément J. F., Mak Anne Linde, Holleboom Adriaan G., Verheij Joanne, Shiri-Sverdlov Ronit, van Mil Saskia W. C., Tushuizen Maarten E., Koek Ger H.

Primary Institution: Amsterdam University Medical Centers

Hypothesis

Can the plasma lipidome serve as a biomarker for different stages of metabolic dysfunction-associated steatotic liver disease (MASLD)?

Conclusion

Plasma lipids may be useful as biomarkers to distinguish between stages of MASLD, particularly in differentiating individuals with metabolic dysfunction-associated steatohepatitis (MASH) from those without.

Supporting Evidence

  • Individuals with MASLD had higher plasma concentrations of sphingolipids, glycerolipids, and glycerophospholipids compared to MASLD-free subjects.
  • Plasma concentrations of specific lipids differed significantly between individuals with and without MASH.
  • PC(36:2) concentrations may help distinguish between MASLD individuals with and without MASH.

Takeaway

This study looked at blood fats to see if they can help tell how bad liver disease is. They found some fats that might help doctors know if someone has a more serious liver problem.

Methodology

The study analyzed the plasma lipid profiles of 39 individuals, including 32 with MASLD and 7 without, using lipidomics to identify and quantify over 1600 lipids.

Potential Biases

The skewed distribution of sex and age among the groups may introduce confounding factors.

Limitations

The study had a limited sample size and an imbalance in participant demographics, which may affect the results.

Participant Demographics

Participants were predominantly Caucasian, overweight, treatment-naïve individuals with hepatic steatosis.

Statistical Information

P-Value

0.0043

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s12944-024-02380-x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication